Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

TRAIL, an apoptosis inducing ligand, has at least four cell surface receptors including the death receptor DR5. Here we report the crystal structure at 2.2 A resolution of a complex between TRAIL and the extracellular region of DR5. TRAIL forms a central homotrimer around which three DR5 molecules b...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Mongkolsapaya, J, Grimes, J, Chen, N, Xu, X, Stuart, D, Jones, E, Screaton, G
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1999

Gelijkaardige items

Expression of TRAIL and TRAIL receptors in normal and malignant tissues.
door: Daniels, R, et al.
Gepubliceerd in: (2005)

Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.
door: Mongkolsapaya, J, et al.
Gepubliceerd in: (1998)

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.
door: Screaton, G, et al.
Gepubliceerd in: (1997)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
door: Anna-Christina Rambow, et al.
Gepubliceerd in: (2022-09-01)

Regulation of ER stress-induced apoptotic and inflammatory responses via YAP/TAZ-mediated control of the TRAIL-R2/DR5 signaling pathway
door: Y. El Yousfi, et al.
Gepubliceerd in: (2025-02-01)

Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression
door: Seok Kim, et al.
Gepubliceerd in: (2018-07-01)

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile
door: Anne V. Yagolovich, et al.
Gepubliceerd in: (2020-04-01)

Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
door: Anna Willms, et al.
Gepubliceerd in: (2019-01-01)

Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.
door: Midgley, C, et al.
Gepubliceerd in: (2012)

Persistent inhibition of ABL tyrosine kinase causes enhanced apoptotic response to TRAIL and disrupts the pro-apoptotic effect of chloroquine.
door: Priya Sridevi, et al.
Gepubliceerd in: (2013-01-01)

Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5
door: Juan LI, et al.
Gepubliceerd in: (2017-02-01)

Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis.
door: Darren Finlay, et al.
Gepubliceerd in: (2010-01-01)

Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL
door: Nesrin Özören, et al.
Gepubliceerd in: (2002-01-01)

Evolution of neurovirulent Zika virus
door: Screaton, G, et al.
Gepubliceerd in: (2017)

Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? The challenges of a dengue vaccine
door: Screaton, G, et al.
Gepubliceerd in: (2018)

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
door: Qiao Chunxia, et al.
Gepubliceerd in: (2012-07-01)

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
door: de Vries Elisabeth GE, et al.
Gepubliceerd in: (2011-01-01)

The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling
door: Jichun Sun, et al.
Gepubliceerd in: (2022-01-01)

CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide
door: Jayaprakasam Madhumathi, et al.
Gepubliceerd in: (2017-03-01)

Specific Incremental Test for Aerobic Fitness in Trail Running: IncremenTrail
door: Grégory Doucende, et al.
Gepubliceerd in: (2022-11-01)

The immunology of Zika virus
door: Culshaw, A, et al.
Gepubliceerd in: (2018)

ASPP--Apoptotic specific regulator of p53.
door: Liu, Z, et al.
Gepubliceerd in: (2005)

NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models
door: A.M. Sheedy, et al.
Gepubliceerd in: (2024-08-01)

Doxorubicin-Loaded Polyelectrolyte Multilayer Capsules Modified with Antitumor DR5-Specific TRAIL Variant for Targeted Drug Delivery to Tumor Cells
door: Anastasia Gileva, et al.
Gepubliceerd in: (2023-02-01)

The release of soluble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients.
door: Magdalena Marcinczyk, et al.
Gepubliceerd in: (2008-06-01)

Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
door: Xin Hua, et al.
Gepubliceerd in: (2021-12-01)

Oxaliplatin Enhances the Apoptotic Effect of Mesenchymal Stem Cells, Delivering Soluble TRAIL in Chemoresistant Colorectal Cancer
door: Adriana G Quiroz-Reyes, et al.
Gepubliceerd in: (2023-10-01)

A Mitochondria-Initiated Apoptotic Pathway
door: Xiaodong Wang
Gepubliceerd in: (2001-01-01)

Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.
door: Cooray, S, et al.
Gepubliceerd in: (2007)

Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia
door: Min Cui, et al.
Gepubliceerd in: (2010-08-01)

The tumor suppressive effect and apoptotic mechanism of TRAIL gene‐containing recombinant NDV in TRAIL‐resistant colorectal cancer HT‐29 cells and TRAIL‐nonresistant HCT116 cells, with each cell bearing a mouse model
door: Bo‐Kyoung Jung, et al.
Gepubliceerd in: (2023-10-01)

Recent advances in understanding dengue [version 1; referees: 3 approved]
door: Sophie Yacoub, et al.
Gepubliceerd in: (2016-01-01)

The immunology of Zika Virus [version 1; referees: 2 approved]
door: Abigail Culshaw, et al.
Gepubliceerd in: (2018-02-01)

Selective targeting of DR5 circumvents resistance of MG-63 osteosarcoma to trail-induced apoptosis
door: Locklin, R, et al.
Gepubliceerd in: (2006)

Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling
door: Xiao Tian, et al.
Gepubliceerd in: (2024-02-01)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
door: Barbara Toffoli, et al.
Gepubliceerd in: (2021-11-01)

Effect of valproic acid on extrinsic (DR4, DR5, FAS, FAS-L, TRAIL) and intrinsic (BAX, BAK and APAF1, Bcl-2, and Bcl-xL) apoptotic pathways, cell viability and apoptosis in hepatocellular carcinoma PLC/PRF5 cell line
door: Masumeh Sanaei, et al.
Gepubliceerd in: (2021-03-01)

Non-apoptotic enteroblast-specific role of the initiator caspase Dronc for development and homeostasis of the Drosophila intestine
door: Jillian L. Lindblad, et al.
Gepubliceerd in: (2021-01-01)

Grafting TRAIL through Either Amino or Carboxylic Groups onto Maghemite Nanoparticles: Influence on Pro-Apoptotic Efficiency
door: Hanene Belkahla, et al.
Gepubliceerd in: (2021-02-01)

Antiproliferative and Apoptotic Effect of Curcumin and TRAIL (TNF Related Apoptosis inducing Ligand) in Chronic Myeloid Leukaemic Cells
door: Bushra Iqbal, et al.
Gepubliceerd in: (2016-04-01)